India to South Africa: Imatinib Export Trade Route

The India to South Africa Imatinib corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $1.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $120.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with imatinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 14.2%, placing it at rank #16 among India's top imatinib export destinations globally.

On the import side, key buyers of Indian imatinib in South Africa include MEDPRO PHARMACEUTICA (PTY) LTD, MEDPRO PHARMACEUTICA PTY LIMITED, MEDPRO PHARMACEUTICA PTY LTD T/A CI and 1 others. MEDPRO PHARMACEUTICA (PTY) LTD is the single largest importer with 6 shipments valued at $857.1K USD.

India's imatinib exports to South Africa are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, MEDWISE OVERSEAS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $120.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as imavec 100mg capsule imatinib mesylate and imavec 100mg capsule (imatinib mesylate(alpha form) capsules 100mg)(ps:6x10x2379pack=142740 nos), suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEDPRO PHARMACEUTICA (PTY) LTD is the largest importer with 6 shipments worth $857.1K USD — representing 71% of all imatinib imports from India on this route.